Drug intelligence / Profile preview

acacia gum allergen extract + ctenocephalides canis allergen extract + ctenocephalides felis allergen extract + karaya gum allergen extract + tragacanth gum allergen extract

Development stage
Unknown
Lead developer
Nelco Laboratories
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

This is an allergenic extract product manufactured by Nelco Laboratories, Inc. formulated as an injectable solution. [2, 5] The product is a combination of five components: allergens from Ctenocephalides canis (dog flea) and Ctenocephalides felis (cat flea) are the primary active ingredients, combined with tragacanth gum, karaya gum, and acacia gum. [10] While the gums can function as excipients, they are also recognized as potential allergens themselves. [4, 8, 17] The product is indicated for both diagnostic testing (e.g., skin tests) and for therapeutic use in allergen-specific immunotherapy (hyposensitization) for patients with allergic disease confirmed by history and skin test reactivity. [3, 11] The mechanism of action for immunotherapy involves the repeated administration of the allergens to desensitize the immune system, leading to an increase in blocking IgG antibodies and a reduction in the IgE-mediated response that causes allergic symptoms. [3]

Other names
tragacanth + karaya gum + acacia + ctenocephalides canis + ctenocephalides felis

Beyond the preview

Go deeper on acacia gum allergen extract + ctenocephalides canis allergen extract + ctenocephalides felis allergen extract + karaya gum allergen extract + tragacanth gum allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acacia gum allergen extract + ctenocephalides canis allergen extract + ctenocephalides felis allergen extract + karaya gum allergen extract + tragacanth gum allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call